Oct 6, 5:01 PM ET
Lamb Weston entered a transition and separation agreement on October 5, 2026 with Marc Schroeder, its President, International, who is resigning. He will stay as President, International through December 31, 2026, then serve in an advisory role until February 15, 2027, and will receive no cash severance.
- Agreement dated October 5, 2026; Schroeder remains President, International through December 31, 2026
- Advisory role continues until February 15, 2027
- Equity vesting is prorated, with non-compete and non-solicitation terms lasting one year after separation
- No cash severance payments; full agreement filed as Exhibit 10.1
Read the filing on SEC.gov ↗
Oct 6, 8:02 AM ET
Lamb Weston reported fiscal first-quarter 2027 net sales up 1% to $1.67 billion, but reported net income fell 55% to $29 million and diluted EPS fell to $0.21 from $0.46. The company raised its full-year fiscal 2027 adjusted diluted EPS outlook to $3.05 to $3.35 from $2.95 to $3.25, and its adjusted EBITDA outlook to $1.125 billion to $1.215 billion from $1.10 billion to $1.20 billion.
- Q1 net sales rose 1% to $1.67 billion; North America sales rose 5% while International sales fell 8%.
- Reported diluted EPS was $0.21 versus $0.46 a year earlier; adjusted diluted EPS was $0.75 versus $0.74.
- Adjusted EBITDA was $286 million, down 5%; International segment Adjusted EBITDA fell 54% to $27 million.
- Fiscal 2027 adjusted diluted EPS outlook raised to $3.05 to $3.35; the company did not repurchase shares in the quarter and $245 million remains authorized for buybacks.
Read the filing on SEC.gov ↗
Jul 24, 8:00 AM ET
Lamb Weston reported fiscal fourth-quarter 2026 net sales up 6% to $1.77 billion, led by a 7% rise in sales volume, but net income fell 9% to $110 million and diluted EPS fell 7% to $0.79. For the full year, net sales exceeded the high end of guidance at $6.61 billion and adjusted EBITDA reached $1.15 billion, yet net income fell 19% to $290 million, and the company issued fiscal 2027 guidance for adjusted diluted EPS of $2.95 to $3.25.
- Q4 net sales rose 6% to $1,770 million, with North America up 9% and International down 2%
- Q4 net income was $110 million and diluted EPS was $0.79, versus $120 million and $0.85 in the prior-year quarter
- Full-year fiscal 2026 net sales of $6,612 million and adjusted EBITDA of $1,147 million both exceeded the high end of guidance
- Fiscal 2027 guidance: adjusted diluted EPS of $2.95 to $3.25 and adjusted EBITDA of $1.1 billion to $1.2 billion
Read the filing on SEC.gov ↗
Jul 15, 5:24 PM ET
Lamb Weston amended its 2026 Inducement Stock Plan on July 13, 2026, reducing the number of common shares authorized for issuance under the plan from 2,000,000 to 1,538,000. The plan is used to grant equity to new hires and returning employees, so the change limits the shares available for those grants.
- Amendment adopted July 13, 2026 by the Compensation and Human Capital Committee
- Authorized shares reduced from 2,000,000 to 1,538,000
- Plan covers individuals not previously employed by the company or returning after a bona fide period of non-employment
- Amended plan filed as Exhibit 10.1
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.